Ovine placental lactogen (oPL), a member of the growth hormone/prolactin ge
ne family, is produced by chorionic binucleate cells at the maternal-fetal
interface, and is thought to modulate metabolic processes and enhance fetal
growth. We have determined that the oPL gene contains five exons and four
introns, and the transcriptional start site was mapped 91 bp 5' of the init
iation codon (AUG). An additional 4.5 kb of 5'-flanking sequence was sequen
ced and used for transient transfection analysis in human (BeWo) and rat (R
cho-1) choriocarcinoma cell lines to examine trophoblast cell-specific acti
vity. Trophoblast cell-specific transactivation of the reporter gene was co
nferred by the proximal 1.1 kb of oPL gene 5'-flanking sequence. Transfecti
on of deletion constructs derived from the 1.1 kb of 5'-flanking sequence r
esulted in varying profiles of transactivation between the two choriocarcin
oma cell lines, but maximal activation in both cell lines resided within th
e proximal 383 bp of oPL gene 5'-flanking sequence. DNase I protection anal
ysis using ovine chorionic binucleate cell nuclear protein, identified 19 f
ootprints within the 1.1-kb sequence, six of which are located within the 3
83-bp region. Electrophoretic mobility-shift assays and mutational analysis
identified two functional GATA (-67, -102) sequences as transactivators of
the oPL gene. However, a previously undefined element (GAGGAG) residing at
-338 and -283 is required for full transactivation, and mutation of either
significantly reduces reporter activity. In addition, an AP-2 site (-58) a
nd an E-box (-163) were identified and may coordinate oPL transactivation.
Transcriptional regulation of human and rodent PL genes has been previously
characterized, and our results indicate that tissue-specific regulation of
oPL expression may result from cis-acting elements in common with human an
d rat genes expressed within the placenta. However, our data indicate that
regulation of oPL also results from novel cis-acting elements.